Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
ACN
Accenture
$316.82
Chart
$279.16 (+13.49%)
$342.18 (-7.41%)
$363.26 (-12.78%)
$286.71 (+10.50%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
ACN
Accenture
Current Price
$316.82
Login to view Accenture (ACN) recommendation from the last 90 days from financial news and social media.
Chart
$279.16 (+13.49%)
$342.18 (-7.41%)
$363.26 (-12.78%)
$286.71 (+10.50%)
ACN Latest Headlines
Healthcares Quiet AI Boom Is Creating a New Class of Breakout Contenders. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – Artificial intelligence is rapidly becoming one of the most promising frontiers in healthcare innovation. Ark Invest'.s to breakthrough research from Mass General Brigham—where AI models identified cancer survival outcomes using facial photographs—as evidence that healthcare may become AI'.s "..". As adoption moves from several tech
Tue May 27, 2025
Healthcares Quiet AI Boom Is Creating a New Class of Breakout Contenders. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – Artificial intelligence is rapidly becoming one of the most promising frontiers in healthcare innovation. Ark Invest'.s to breakthrough research from Mass General Brigham—where AI models identified cancer survival outcomes using facial photographs—as evidence that healthcare may become AI'.s "..". As adoption moves from several tech
Tue May 27, 2025
Healthcares Quiet AI Boom Is Creating a New Class of Breakout Contenders. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – Artificial intelligence is rapidly becoming one of the most promising frontiers in healthcare innovation. Ark Invest'.s to breakthrough research from Mass General Brigham—where AI models identified cancer survival outcomes using facial photographs—as evidence that healthcare may become AI'.s "..". As adoption moves from several tech
Tue May 27, 2025
Accenture Nvidia and Dell Technologies Partner to Capitalize on Growing AI Demand.
Fri May 23, 2025
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – A from Philips reveals a when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes only 48% of patients share that optimism. As what'.s needed for successful AI adoption in healthcare major players in tech and biotech are already moving ahead—recent updates h
Fri May 23, 2025
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – A from Philips reveals a when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes only 48% of patients share that optimism. As what'.s needed for successful AI adoption in healthcare major players in tech and biotech are already moving ahead—recent updates h
Fri May 23, 2025
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – A from Philips reveals a when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes only 48% of patients share that optimism. As what'.s needed for successful AI adoption in healthcare major players in tech and biotech are already moving ahead—recent updates h
Fri May 23, 2025
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge. News CommentaryIssued on behalf of Avant Technologies Inc. News Commentary – A from Philips reveals a when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes only 48% of patients share that optimism. As what'.s needed for successful AI adoption in healthcare major players in tech and biotech are already moving ahead—recent updates h
Fri May 23, 2025
Demystifying Accenture: Insights From 14 Analyst Reviews. Analysts'. ratings for Accenture (NYSE:) over the last quarter vary from ish to bearish as provided by 14 analysts.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.4820010000000000200036200Analysts have set 12-month price targets for Accenture revealing an average target of $382.57 a high estimate of $398.00 and a low estima
Thu May 22, 2025
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades and downgrades please see our analyst ratings page.Needham raised ) price target from $215 to $230. Needham analyst Mike Cikos maintained a Buy rating. Snowflake shares closed at $179.12 on Wednesday. See how other analysts view this stock.HC Wainwright &. Co. boosted the price
Thu May 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
